21 September 2022
Par-backed Cumulus Neuroscience has appointed Digital Health and Pharmaceutical Executive Aman H. Bhatti, MD as CEO to lead the Company into its next stage of growth as it develops its AI-based digital biomarker platform to accelerate patient care and drug development in neuroscience
Read more here: https://prn.to/3Uok7s2
Related companies:
